• Privacy Policy
  • Terms and Conditions
  • Contact
Sunday, August 2, 2026
Pharma Info Nepal
  • Home
  • Vacancy
  • Courses
  • License
  • Loksewa
  • Questions
  • Downloads
  • Pharmacy Books
    • Pharmacy Act and Guidelines
    • Study Materials
  • Pharmacy Notes
    • B Pharmacy
    • D Pharmacy
No Result
View All Result
  • Home
  • Vacancy
  • Courses
  • License
  • Loksewa
  • Questions
  • Downloads
  • Pharmacy Books
    • Pharmacy Act and Guidelines
    • Study Materials
  • Pharmacy Notes
    • B Pharmacy
    • D Pharmacy
No Result
View All Result
Pharma Info Nepal
No Result
View All Result
Home Study Materials

Classification of Antihypertensive Drugs

Classification of Antihypertensive Drugs

Pharma Info Nepal by Pharma Info Nepal
August 2, 2026
in Study Materials
0
Classification of Antihypertensive Drugs
2
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Classification of Antihypertensive Drugs

Classification of Antihypertensive Drugs: Complete Guide for Pharmacy Students

High blood pressure (hypertension) is one of the leading risk factors for cardiovascular diseases such as stroke, myocardial infarction, heart failure, and chronic kidney disease. Antihypertensive drugs help reduce blood pressure by acting through different mechanisms, including reducing blood volume, relaxing blood vessels, decreasing cardiac output, or inhibiting the renin-angiotensin-aldosterone system (RAAS).

Understanding the classification of antihypertensive drugs is essential for pharmacy students preparing for Nepal Pharmacy Council (NPC), Lok Sewa, B.Pharm, D.Pharm, and M.Pharm entrance examinations.

Classification of Antihypertensive Drugs

Antihypertensive drugs are broadly classified into five major groups:

ADVERTISEMENT
  1. Diuretics
  2. Renin-Angiotensin System (RAS) Inhibitors
  3. Sympathetic Inhibitors
  4. Calcium Channel Blockers (CCBs)
  5. Vasodilators

Classification of Antihypertensive Drugs

1. Diuretics

Diuretics lower blood pressure by increasing sodium and water excretion, thereby reducing blood volume and cardiac output.

A. Thiazide Diuretics

Examples

  • Hydrochlorothiazide
  • Chlorthalidone
  • Indapamide

Mechanism of Action

  • Inhibit Na⁺/Cl⁻ cotransporter in the distal convoluted tubule.
  • Increase sodium and water excretion.
  • Long-term use decreases peripheral vascular resistance.

Clinical Uses

  • First-line treatment of hypertension
  • Mild edema
  • Heart failure

Important Adverse Effects

  • Hypokalemia
  • Hyperuricemia
  • Hyperglycemia
  • Hyponatremia

B. High Ceiling (Loop) Diuretics

Examples

  • Furosemide
  • Bumetanide
  • Torsemide

Mechanism

  • Inhibit Na⁺-K⁺-2Cl⁻ transporter in the loop of Henle.
  • Produce powerful diuresis.

Uses

  • Hypertension with renal impairment
  • Pulmonary edema
  • Congestive heart failure

Adverse Effects

  • Hypokalemia
  • Ototoxicity
  • Dehydration

C. Potassium-Sparing Diuretics

Examples

  • Spironolactone
  • Eplerenone
  • Amiloride

Mechanism

  • Aldosterone antagonists (Spironolactone, Eplerenone)
  • ENaC blocker (Amiloride)

Advantages

  • Prevent potassium loss
  • Useful in resistant hypertension

Adverse Effects

  • Hyperkalemia
  • Gynecomastia (Spironolactone)

2. Renin-Angiotensin System (RAS) Inhibitors

These drugs inhibit the RAAS pathway responsible for vasoconstriction and sodium retention.

A. ACE Inhibitors

Examples

  • Captopril
  • Enalapril
  • Lisinopril
  • Ramipril
  • Perindopril
  • Quinapril
  • Fosinopril
  • Trandolapril

Mechanism

  • Block conversion of Angiotensin I to Angiotensin II.
  • Increase bradykinin levels.
  • Cause vasodilation.

Clinical Uses

  • Hypertension
  • Heart failure
  • Diabetic nephropathy
  • Post-myocardial infarction

Adverse Effects

  • Dry cough
  • Hyperkalemia
  • Angioedema
  • Contraindicated in pregnancy

B. Angiotensin II (AT₁) Receptor Blockers (ARBs)

Examples

  • Losartan
  • Valsartan
  • Candesartan
  • Telmisartan
  • Irbesartan
  • Olmesartan

Mechanism

  • Block AT₁ receptors.
  • Prevent vasoconstriction and aldosterone secretion.

Advantages

  • Similar efficacy to ACE inhibitors
  • No bradykinin-induced cough

Adverse Effects

  • Hyperkalemia
  • Hypotension
  • Contraindicated during pregnancy

C. Direct Renin Inhibitor

Example

  • Aliskiren

Mechanism

  • Directly inhibits renin activity.
  • Prevents formation of Angiotensin I.

Uses

  • Essential hypertension

Adverse Effects

  • Hyperkalemia
  • Diarrhea
  • Hypotension

3. Sympathetic Inhibitors

These drugs decrease sympathetic nervous system activity, reducing heart rate, cardiac output, and vascular resistance.

A. β-Adrenergic Blockers (Beta Blockers)

Examples

  • Propranolol
  • Atenolol
  • Metoprolol

Mechanism

  • Block β₁ receptors in the heart.
  • Decrease heart rate and cardiac output.
  • Reduce renin secretion.

Uses

  • Hypertension
  • Angina
  • Arrhythmias
  • Heart failure (selected agents)

Adverse Effects

  • Bradycardia
  • Fatigue
  • Bronchospasm (non-selective agents)

B. α + β Adrenergic Blockers

Examples

  • Labetalol
  • Carvedilol

Mechanism

  • Block both α and β receptors.
  • Reduce heart rate and peripheral resistance.

Uses

  • Hypertensive emergencies
  • Heart failure
  • Pregnancy-induced hypertension (Labetalol)

C. α-Adrenergic Blockers

Examples

  • Prazosin
  • Terazosin
  • Doxazosin
  • Phentolamine
  • Phenoxybenzamine

Mechanism

  • Block α₁ receptors.
  • Cause vasodilation.

Uses

  • Hypertension
  • Benign prostatic hyperplasia (BPH)

Adverse Effects

  • Orthostatic hypotension
  • Dizziness
  • First-dose syncope

D. Central Sympatholytics

Examples

  • Clonidine
  • Methyldopa

Mechanism

  • Stimulate central α₂ receptors.
  • Reduce sympathetic outflow.

Uses

  • Resistant hypertension
  • Hypertension during pregnancy (Methyldopa)

Adverse Effects

  • Sedation
  • Dry mouth
  • Rebound hypertension (Clonidine)

4. Calcium Channel Blockers (CCBs)

Calcium channel blockers inhibit L-type calcium channels, causing vasodilation and reduced myocardial contractility.

A. Phenylalkylamine

Example

  • Verapamil

Characteristics

  • Greater effect on the heart
  • Used in hypertension and arrhythmias

B. Benzothiazepine

Example

  • Diltiazem

Characteristics

  • Intermediate effect on heart and blood vessels

C. Dihydropyridines

Examples

  • Amlodipine
  • Nifedipine
  • Felodipine
  • Nicardipine
  • Lercanidipine
  • Lacidipine
  • Benidipine

Characteristics

  • Predominantly vasodilators
  • Common first-line antihypertensive drugs

Adverse Effects

  • Peripheral edema
  • Flushing
  • Headache
  • Reflex tachycardia (short-acting agents)

5. Vasodilators

These drugs directly relax vascular smooth muscle.

A. Arteriolar Dilators

Examples

  • Hydralazine
  • Minoxidil
  • Diazoxide

Mechanism

  • Dilate arterioles.
  • Reduce peripheral vascular resistance.

Uses

  • Resistant hypertension
  • Hypertensive emergencies (Hydralazine)

Adverse Effects

  • Reflex tachycardia
  • Fluid retention
  • Hypertrichosis (Minoxidil)
  • Drug-induced lupus (Hydralazine)

B. Arteriolar and Vasodilator

Example

  • Sodium Nitroprusside

Mechanism

  • Releases nitric oxide (NO).
  • Dilates both arteries and veins.

Uses

  • Hypertensive emergencies
  • Acute heart failure

Important Adverse Effect

  • Cyanide toxicity during prolonged infusion

Summary Table

Class Main Examples Mechanism
Thiazide Diuretics Hydrochlorothiazide, Chlorthalidone Increase sodium and water excretion
Loop Diuretics Furosemide Potent diuresis
Potassium-Sparing Diuretics Spironolactone, Amiloride Prevent potassium loss
ACE Inhibitors Enalapril, Ramipril Block Angiotensin I → II conversion
ARBs Losartan, Telmisartan Block AT₁ receptors
Direct Renin Inhibitor Aliskiren Inhibits renin
Beta Blockers Atenolol, Metoprolol Reduce heart rate and renin release
Alpha Blockers Prazosin Vasodilation
Central Sympatholytics Clonidine, Methyldopa Reduce sympathetic outflow
Calcium Channel Blockers Amlodipine, Verapamil, Diltiazem Block calcium channels
Vasodilators Hydralazine, Minoxidil, Nitroprusside Direct vascular smooth muscle relaxation

High-Yield Exam Points

  • Thiazide diuretics are considered first-line drugs for uncomplicated hypertension.
  • ACE inhibitors commonly cause a dry cough due to increased bradykinin.
  • ARBs do not usually cause cough and are suitable alternatives when ACE inhibitors are not tolerated.
  • Spironolactone may cause gynecomastia and hyperkalemia.
  • Methyldopa and Labetalol are preferred antihypertensive drugs during pregnancy.
  • Amlodipine is one of the most commonly prescribed calcium channel blockers for hypertension.
  • Sodium nitroprusside is mainly used for hypertensive emergencies.
  • Hydralazine may cause drug-induced lupus erythematosus.
  • Minoxidil can cause hypertrichosis (excessive hair growth).
  • Aliskiren is the only clinically used direct renin inhibitor.

Antihypertensive drugs are classified based on their mechanism of action into diuretics, RAS inhibitors, sympathetic inhibitors, calcium channel blockers, and vasodilators. A clear understanding of their classification, mechanisms, examples, clinical uses, and adverse effects is essential for pharmacy practice and competitive examinations such as the Nepal Pharmacy Council License Exam, Lok Sewa, D.Pharm, B.Pharm, and M.Pharm entrance exams.

 



  • Classification of Antiemetics Drugs
  • Classification of Antidepressant Drugs
Tags: Classification of Antihypertensive DrugsStudy Materials
Previous Post

DDA Notice Regarding Submission of Additional Documents for Pharmacy Registration and Renewal

Pharma Info Nepal

Pharma Info Nepal

Pharma Info Nepal is Nepal's leading pharmacy education and information platform, dedicated to pharmacists, pharmacy students, and healthcare professionals. We provide trusted pharmacy news, regulatory updates, NPC and Loksewa exam resources, verified job opportunities, scholarships, research insights, and professional guidance to support excellence in pharmacy practice and education.

Related Posts

Good Manufacturing Practice (GMP) and Elements of GMP
B Pharmacy

Good Manufacturing Practice (GMP) and Elements of GMP

July 29, 2026
Pharma Info Nepal Class
License

Demo Class Pharma Info Nepal

May 16, 2026
Updated Guidelines on the Treatment of Drug-Susceptible and Drug-Resistant TB
Downloads

Updated Guidelines on the Treatment of Drug-Susceptible and Drug-Resistant TB

February 10, 2026
Classification of Antidepressant Drugs
Pharmacology

Classification of Antidepressant Drugs

October 4, 2025
Load More

Recommended

Classification of Antihypertensive Drugs

Classification of Antihypertensive Drugs

August 2, 2026
DDA Notice Regarding Submission of Additional Documents for Pharmacy Registration and Renewal

DDA Notice Regarding Submission of Additional Documents for Pharmacy Registration and Renewal

August 2, 2026
Nepal's Pharmaceutical Industry Roadmap: WHO GMP Certification and Domestic Medicine Production Targets

Nepal’s Pharmaceutical Industry Roadmap: WHO GMP Certification and Domestic Medicine Production Targets

August 1, 2026
DDA Nepal's Journey Toward a Stronger Drug Regulatory System: Targeting WHO Maturity Level 3 by 2027

DDA Nepal’s Journey Toward a Stronger Drug Regulatory System: Targeting WHO Maturity Level 3 by 2027

August 1, 2026
Good Manufacturing Practice (GMP) and Elements of GMP

Good Manufacturing Practice (GMP) and Elements of GMP

July 29, 2026
ADVERTISEMENT
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

About Pharma Info Nepal

Pharma Info Nepal is a dedicated platform led by Nabin Bista, focused on empowering pharmacy students and professionals in Nepal. We provide high-quality educational resources, exam preparation materials, and professional guidance for pharmacy licensure exams and beyond. Our mission is to uplift the pharmacy profession in Nepal by fostering knowledge, skills, and excellence in pharmaceutical practice.

Explore our services, stay updated on pharmacy trends, and join a community striving for innovation and professionalism in healthcare.

IMPORTANT INFORMATION

All content available on this website, including text, images, files, and other resources, is strictly protected under applicable copyright and intellectual property laws. Any reuse, reproduction, or redistribution of materials without prior written permission from Pharma Info Nepal is prohibited and may result in legal action.

Pharma Info Nepal operates as a registered company dedicated to maintaining the authenticity and integrity of its content and services.

Thank you for respecting our policies and supporting our mission to advance pharmacy education and practice.

CATEGORIES

  • B Pharmacy
  • Colleges
  • D Pharmacy
  • Downloads
  • License
  • Loksewa
  • M Pharmacy
  • Medicinal Chemistry
  • Notice
  • Nursing
  • Pharmacognosy
  • Pharmacology
  • Pharmacy Notes
  • Questions
  • Scholarship
  • Study Materials
  • Syllabus
  • Updates
  • Vacancy
  • Home
  • Vacancy
  • Courses
  • License
  • Loksewa
  • Questions
  • Downloads
  • Pharmacy Books
  • Pharmacy Notes

© 2026 Pharma Info Nepal Pvt. Ltd | All Rights Reserved

error:
No Result
View All Result
  • Home
  • Courses
  • Questions
  • Downloads
  • About Pharma Info Nepal 

© 2026 Pharma Info Nepal Pvt. Ltd | All Rights Reserved